Ocular Therapeutix (NASDAQ:OCUL) Stock Rating Reaffirmed by Piper Sandler
Ocular Therapeutix (NASDAQ:OCUL – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at Piper Sandler in a note issued to investors on Friday, Benzinga reports. They presently have a $15.00 target price on the biopharmaceutical company’s stock. Piper Sandler’s target price would suggest a potential upside of 145.50% from the stock’s […]
More Stories
Brighthouse Financial, Inc. (NASDAQ:BHFAP) Sees Significant Increase in Short Interest
Brighthouse Financial, Inc. (NASDAQ:BHFAP – Get Free Report) was the target of a significant growth in short interest in September....
US Strikes Kill 37 ISIS Operatives, Terrorists in Syria
By Jackson Richman The United States killed 37 terrorist group members, including leaders tied to ISIS and Al Qaeda affiliate...
BlackRock High Yield ETF (NASDAQ:BRHY) Short Interest Down 27.3% in September
BlackRock High Yield ETF (NASDAQ:BRHY – Get Free Report) was the target of a significant decrease in short interest during...
Federal Major Disaster Declared for North Carolina, Florida After Helene
By Jack Phillips President Joe Biden on Sunday approved a federal major disaster in North Carolina and Florida after storm...
ICE: Over 425,000 Criminal Illegal Immigrants Not in Agency’s Custody, Including 13,099 Convicted Killers
By Tom Ozimek Federal immigration authorities have revealed that more than 425,000 illegal immigrants convicted of crimes, including more than...
Short Interest in Powszechna Kasa Oszczednosci Bank Polski Spólka Akcyjna (OTCMKTS:PSZKY) Rises By 40.0%
Powszechna Kasa Oszczednosci Bank Polski Spólka Akcyjna (OTCMKTS:PSZKY – Get Free Report) was the recipient of a significant growth in...